How the hunger for a new weight loss drug is feeding an industry of fakes

• Counterfeit weight loss drugs are proliferating on the black market, posing significant patient safety risks from unregulated manufacturing and unknown contents
• Demand for novel weight loss medications in clinical trials is driving illicit supply chains, highlighting need for patient education on legitimate prescribing pathways
• Clinicians should counsel patients against sourcing medications outside regulated channels and be alert to complications from counterfeit preparations

Counterfeit versions of a drug which is still in clinical trials are flooding the black market.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.